7:35 PM Jun 19, 2018

Channel your outrage

Before the dust settles on the PABNAB debacle, save some outrage for what really matters: not the periodic stripper party that screams “sickening,” but the entrenched attitudes and daily...

8:35 PM Jun 15, 2018

MATCH’s long game

Although three of the first four arms in NCI-MATCH missed their endpoints, the results suggest the basket trial is doing what it is supposed to -- finding efficacy signals in rare cancers. It’s...

5:25 PM Jun 15, 2018

NSCLC disrupted

This year’s ASCO made clear that PD-1 inhibitors have supplanted chemotherapy as standard of care in first-line metastatic NSCLC. The unanticipated consequence is the knock-on effects for...

3:21 PM Jun 15, 2018

Safer harbor

FDA guidance released on June 12 clears up regulatory ambiguities that have restricted drug and device company communications with payers, physicians and patients. A primary goal is to make it...

4:55 PM Jun 14, 2018

Meta on data

NIH is grasping the nettle and turning its attention to solving the big practical questions about big data. Stopping short of a vision for how data science should drive discovery, NIH has laid out...

1
2
3
4
5

Latest News

2:06 PM Jun 21, 2018

Beacon to develop right-to-try patient match platform

Beacon Pharmaceutical (New York, N.Y.) said it will launch a new platform to connect terminally ill...

2:05 PM Jun 21, 2018

UCSD launches bacteriophage treatment center

The University of California San Diego launched the Center for Innovative Phage Applications and...

1:52 PM Jun 21, 2018

Novo expands market cap on oral semaglutide data

Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) added DKK20.4 billion ($3.2 billion) in market cap in Copenhagen...

1:40 PM Jun 21, 2018

FDA releases draft guidance for antidepressant trials

FDA published draft guidance on developing drugs for major depressive disorder, which when finalized will...

11:57 AM Jun 21, 2018

Heron flying on Phase IIb pain data ahead of NDA

Heron Therapeutics Inc. (NASDAQ:HRTX) added $9.25 (30%) to $39.95 on Thursday after reporting that HTX-011...

10:48 AM Jun 21, 2018

FDA scraps biosimilars draft guidance

In an effort to reduce the cost and increase the efficiency of biosimilars development, FDA Thursday...

7:14 AM Jun 21, 2018

Rhythm raises $151.4M in follow-on

Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) raised $151.4 million through the sale of 5.7 million shares at $...

9:46 PM Jun 20, 2018

Four companies in IPO quintet post first-day gains

Four of the five biopharmas that priced IPOs late Wednesday posted gains in early afternoon trading...

4:00 PM Jun 20, 2018

Gawande to head Amazon-Berkshire-Chase healthcare company

Amazon.com Inc. (NASDAQ:AMZN), Berkshire Hathaway Inc. (NYSE:BRK.A; NYSE:BRK.B) and JPMorgan Chase &...

3:54 PM Jun 20, 2018

Broad ErbB inhibition arrests KRAS mutant cancer

Multi-ErbB inhibitors may provide a treatment option for K-Ras (KRAS)-driven lung cancer where ErbB family...

3:45 PM Jun 20, 2018

Management tracks: Sanofi, NantKwest

Sanofi (Euronext:SAN; NYSE:SNY) hired Jean-Baptiste Chasseloup de Chatillon as EVP and CFO, effective Oct....

3:40 PM Jun 20, 2018

Roche, Tesaro decline to comment on potential bid

Roche (SIX:ROG; OTCQX:RHHBY) and Tesaro Inc. (NASDAQ:TSRO) declined to comment on an Intereconomía report...

3:18 PM Jun 20, 2018

TRPV4 could be new target for brain edema

University of Tokyo researchers and colleagues found inhibiting transient receptor potential vanilloid 4 (...

2:18 PM Jun 20, 2018

Senate rejects clawback attempt

The Senate rejected a bill on Wednesday that would have rescinded more than $7 billion previously approved...

1:13 PM Jun 20, 2018

ObsEva raises $73M on heels of linzagolix data

ObsEva S.A. (NASDAQ:OBSV) raised $73.1 million through the sale of 4.8 million shares at $15.39 in a...

1:02 PM Jun 20, 2018

TG, Novimmune developing CD47/CD19 bispecific

TG Therapeutics Inc. (NASDAQ:TGTX) partnered with Novimmune S.A. (Plan-les-Ouates, Switzerland) to develop...

12:50 PM Jun 20, 2018

FDA panel to review Paratek antibiotic

FDA's Antimicrobial Drugs Advisory Committee has scheduled an Aug. 8 meeting to discuss two NDAs for...

11:45 AM Jun 20, 2018

Galmed raises $75M follow-on

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) raised $75 million through the sale of 5 million shares at $15...

7:24 AM Jun 20, 2018

Aminex raises $10M, starts Phase I cancer trial

Aminex Therapeutics Inc. (Seattle, Wash.) raised $10 million in an untranched series B round. The company...

7:15 AM Jun 20, 2018

Eidos gets first-day bump after pricing IPO at top of range

Eidos Therapeutics Inc. (NASDAQ:EIDX) added $6.12 (36%) to $23.12 Wednesday after raising $106.3 million...

Down Up